A targetable MYBL2-ATAD2 axis governs cell proliferation in ovarian cancer.
Liu Q, Liu H, Huang X, Fan X, Xiao Z, Yan R, Yao J, An G, Ge Y, Miao J, Liu J.
Liu Q, et al. Among authors: yan r.
Cancer Gene Ther. 2023 Jan;30(1):192-208. doi: 10.1038/s41417-022-00538-2. Epub 2022 Sep 23.
Cancer Gene Ther. 2023.
PMID: 36151333